Aquarius Surgical Technologies Inc.
AQQRF
$0.00
$0.000.00%
OTC PK
| 12/31/2025 | 09/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 19.85% | 7.09% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 19.85% | 7.09% | |||
| Cost of Revenue | 27.27% | 13.79% | |||
| Gross Profit | 12.86% | 1.45% | |||
| SG&A Expenses | -52.68% | 13.24% | |||
| Depreciation & Amortization | -67.35% | 2.08% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -47.39% | 12.57% | |||
| Operating Income | 60.20% | -13.69% | |||
| Income Before Tax | 28.00% | -213.19% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 28.55% | -214.07% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 28.55% | -214.07% | |||
| EBIT | 60.20% | -13.69% | |||
| EBITDA | 59.67% | -6.48% | |||
| EPS Basic | 28.64% | -214.52% | |||
| Normalized Basic EPS | 30.30% | -6.45% | |||
| EPS Diluted | 28.64% | -214.52% | |||
| Normalized Diluted EPS | 30.30% | -6.45% | |||
| Average Basic Shares Outstanding | 0.00% | 0.00% | |||
| Average Diluted Shares Outstanding | 0.00% | 0.00% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||